Company: CSTL
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001447362-25-000031
Chunk: 12

Company: CASTLE BIOSCIENCES INC
Filing Date: 2025-02-27
Form: 10-K
Item: Item 5
Chunk 12
---
 in cash and cash equivalent securities or highly liquid investment securities.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

Stock Performance Graph

The following information is not deemed to be "soliciting material" or to be "filed" with the SEC or subject to Regulation 14A or 14C under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or to the liabilities of Section 18 of the Exchange Act, and will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent we specifically incorporate it by reference into such a filing.

75

Table of Contents

The graph below compares the cumulative total stockholder return of our common stock to the Nasdaq Composite Index and the Nasdaq Biotechnology Total Return Index. The graph and table below assume that $100 was invested on December 31, 2019, and dividends, if any, were reinvested on the date of payment without payment of any commissions. The comparisons in the table are required by the SEC and are not intended to forecast or be indicative of future performance of our common stock.

12/31/201912/31/202012/31/202112/31/202212/31/202312/31/2024Castle Biosciences, Inc.$100.00 $195.37 $124.73 $68.49 $62.79 $77.54 Nasdaq Composite Index$100.00 $143.64 $174.36 $116.65 $167.30 $215.22 Nasdaq Biotechnology Total Return Index$100.00 $125.46 $125.49 $112.78 $117.96 $117.30